Beauty equipment market is expected to grow significantly due to the rising consumer preference for non-invasive and minimally invasive aesthetic treatments, increasing awareness regarding skincare and anti-aging procedures, and growing demand for technologically advanced beauty devices. The expanding adoption of laser therapy, radiofrequency, ultrasound therapy, and micro-needle therapy systems across aesthetics clinics, spas, and beauty centers is further contributing to market growth. In addition, increasing disposable income, rapid urbanization, and the growing influence of social media beauty trends are encouraging consumers to invest in advanced cosmetic treatment solutions. Continuous technological advancements in beauty devices and increasing demand for skin tightening, wrinkle reduction, whitening, and acne treatment procedures are anticipated to support the market growth at a CAGR of 12.5% during the forecast period.

Absorption chillers market is witnessing significant growth due to the rising demand for energy-efficient and environmentally sustainable cooling solutions across industrial and commercial sectors. Increasing adoption of waste heat recovery systems, stringent environmental regulations regarding greenhouse gas emissions, and growing focus on reducing electricity consumption are driving the demand for absorption chillers globally. Industries including chemicals, food & beverages, paper & pulp, and power generation are increasingly deploying absorption chillers to improve operational efficiency and lower energy costs. Additionally, rapid industrialization, expanding district cooling projects, and advancements in lithium bromide and ammonia-based technologies are further supporting market expansion during the forecast period.

US oncology information system (OIS) market was valued at $1.3 billion in 2025 and is projected to reach $3.1 billion by 2035, registering a CAGR of 8.9% from 2026 to 2035. Market growth is primarily driven by the increasing burden of cancer and the rapid adoption of digital healthcare solutions. According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, accounting for nearly 10 million casualties annually. In the United States, the rising incidence of cancer and the growing need for efficient patient data management, treatment planning, and clinical decision support are accelerating the adoption of oncology information systems across hospitals and cancer treatment centers. These systems enable integration of imaging, diagnostics, and treatment workflows, significantly improving patient outcomes and operational efficiency.

US myocardial infarction market was valued at $3.3 billion in 2025 and is projected to reach $5.8 billion by 2035, registering a CAGR of 5.8% during the forecast period. Market growth is primarily driven by the rising prevalence of cardiovascular diseases, continuous advancements in interventional cardiology devices, and the increasing adoption of advanced diagnostic technologies. The growing preference for minimally invasive procedures, along with the expanding use of long-term pharmacological therapies, is further supporting market expansion. In addition, improvements in healthcare infrastructure and the strengthening of emergency cardiac care systems are contributing significantly to revenue growth across various treatment segments.

US indapamide market was valued at $203.0 million in 2025 and is projected to reach $261.3 million by 2035, growing at a CAGR of 2.6% during 2026 to 2035. The rising prevalence of hypertension and cardiovascular diseases in the United States is a key factor driving demand for effective antihypertensive medications such as indapamide. As a thiazide-like diuretic, indapamide plays a critical role in blood pressure management, particularly in patients requiring long-term therapy and combination treatment approaches. Increasing awareness of early diagnosis, along with expanding treatment adherence initiatives, is further supporting consistent prescription volumes across the country.

US Enterprise Asset Management Market Size was valued at $2.9 billion in 2025 and is projected to reach $6.6 billion by 2035, expanding at a CAGR of 8.6% during 2026–2035. The growth trajectory is being driven by increasing digital transformation across asset-intensive sectors such as energy, manufacturing, and utilities. A major macro driver is the rapid expansion of infrastructure and industrial asset bases. According to the U.S. Energy Information Administration, the United States maintains over 1.2 million miles of electricity transmission infrastructure, highlighting the massive scale of assets requiring monitoring and lifecycle management. This growing asset footprint is accelerating the adoption of enterprise asset management (EAM) solutions to improve operational efficiency and reduce downtime.

US dredging market was valued at $5.8 billion in 2025 and is projected to reach $8.8 billion by 2035, expanding at a CAGR of 4.3% during 2026–2035. The market growth is primarily driven by increasing maritime trade, port infrastructure modernization, and coastal resilience initiatives. Dredging plays a critical role in maintaining navigable waterways, supporting offshore energy projects, and enabling large-scale infrastructure development. Capital and maintenance dredging activities continue to dominate demand as the United States strengthens its logistics network, port efficiency, and coastal protection systems to handle rising cargo volumes and climate-related challenges.

UK oncology information system market was valued at $222.2 million in 2025 and is projected to reach $503.2 million by 2035, registering a CAGR of 8.6% during the forecast period. Market growth is primarily driven by the rising cancer burden and increasing demand for integrated digital healthcare solutions. According to the World Health Organization, cancer is one of the leading causes of death worldwide, accounting for nearly 10 million casualties annually. In the UK, the increasing incidence of cancers such as breast, lung, and colorectal cancer is significantly boosting the demand for efficient patient data management, treatment planning, and workflow optimization systems across hospitals and oncology centers. This growing clinical burden is accelerating the adoption of oncology information systems to enhance treatment outcomes and operational efficiency.

UK indapamide market was valued at $81.3 million in 2025 and is projected to reach $121.3 million by 2035, growing at a CAGR of 4.2% during 2026 to 2035. The steady rise in hypertension prevalence and cardiovascular disease burden across the United Kingdom is significantly driving demand for thiazide-like diuretics such as indapamide. As a first-line or adjunct therapy for blood pressure management, indapamide plays a critical role in reducing stroke risk, heart failure incidence, and long-term cardiovascular complications.

The global race toward enterprise AI adoption is accelerating at an unprecedented pace. Organizations are investing heavily in large language models, generative AI systems, AI copilots, intelligent automation, and real-time analytics to gain a competitive advantage. However, as AI deployments scale, enterprises are discovering that model performance alone is no longer the primary determinant of success. The real challenge lies in understanding the Total Cost of Ownership (TCO) associated with AI infrastructure.